Innate Pharma Logo

Innate Pharma

Clinical-stage biotech developing NK cell-engaging antibodies for cancer immunotherapy.

IPH | PA

Overview

Corporate Details

ISIN(s):
FR0010331421 (+1 more)
LEI:
9695002Y8420ZB8HJE29
Country:
France
Address:
117 AVENUE DE LUMINY, 13009 MARSEILLE
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Innate Pharma SA is a global, clinical-stage biotechnology company specializing in immuno-oncology. Founded in 1999 by pioneers in innate immunity, the company is dedicated to developing innovative therapeutic antibodies that harness the body's immune system to fight cancer. Its pipeline features proprietary and partnered drug candidates derived from its expertise in Natural Killer (NK) cell biology. A key proprietary technology is the ANKET® (Antibody-based NK cell Engager Therapeutics) platform, which generates multispecific antibodies to engage NK cells against tumors. The company focuses on addressing high unmet medical needs for cancer patients through its novel immunotherapies.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-22 13:41
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
French 487.1 KB
2025-09-02 07:00
Declaration of Voting Results & Voting Rights Announcements
Total number of voting rights and capital / Information on the total number of …
English 157.7 KB
2025-09-02 07:00
Declaration of Voting Results & Voting Rights Announcements
Total du nombre de droits de vote et du capital / Information relative au nombr…
French 135.3 KB
2025-07-11 11:24
Major Shareholding Notification
Franchissements de seuils
French 116.0 KB
2025-06-17 07:00
Investor Presentation
Informations privilégiées / Autres communiqués
French 165.5 KB
2025-06-17 07:00
Regulatory News Service
Inside Information / Other news releases
English 204.3 KB
2025-06-13 07:00
Regulatory News Service
Informations privilégiées / Autres communiqués
French 179.5 KB
2025-06-13 07:00
Regulatory News Service
Inside Information / Other news releases
English 273.5 KB
2025-05-27 07:00
Report Publication Announcement
Inside Information / Other news releases
English 210.2 KB
2025-05-27 07:00
Regulatory News Service
Informations privilégiées / Autres communiqués
French 173.9 KB
2025-05-23 07:00
Post-Annual General Meeting Information
Inside Information / Other news releases
English 232.8 KB
2025-05-23 07:00
Regulatory News Service
Inside Information / Other news releases
English 230.4 KB
2025-05-23 07:00
Earnings Release
Informations privilégiées / Autres communiqués
French 188.7 KB
2025-05-19 07:00
Regulatory News Service
Inside Information / Other news releases
English 181.7 KB
2025-05-19 07:00
Regulatory News Service
Informations privilégiées / Autres communiqués
French 148.3 KB

Automate Your Workflow. Get a real-time feed of all Innate Pharma filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Innate Pharma via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-01-10 N/A Other Buy 6,000 N/A
2024-01-02 N/A Other Buy 20,000 N/A

Peer Companies

Company Country Ticker View
1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain IKM
AI-powered genome sequencing and reanalysis to diagnose rare diseases globally.
South Korea 394800
Develops antibody therapeutics and CAR-T for oncology and provides CRO services.
South Korea 174900
Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.
South Korea 203400
ABL Bio Inc. Logo
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea 298380
Acticor Biotech Logo
Clinical-stage biopharma developing a first-in-class drug for thrombotic diseases like stroke.
France ALACT
Adecco Group AG Logo
Global talent solutions firm offering staffing, placement, career transition, and tech consulting.
Switzerland ADI1
ADforus Co., Ltd. Logo
Ad-tech firm with AI platforms for mobile marketing and publisher monetization solutions.
South Korea 397810
Adocia Logo
Biotech improving protein drug formulations for diabetes & obesity and developing cell therapies.
France ADOC
ad pepper media International N.V. Logo
Global performance marketing & audience targeting solutions for advertisers and agencies worldwide.
Germany APM

Talk to a Data Expert

Have a question? We'll get back to you promptly.